63
Growth Score in past quarter
pts
Heat Score 63 in past quarter
20 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
618056
Orbit Biomedical is to revolutionize gene and cell therapy treatment by setting a new standard for precise, targeted surgical delivery.
- Dave Bourdeau: Chief Experience and Education Officer
About the Company
Orbit Biomedical’s mission is to revolutionize gene and cell therapy treatment by setting a new standard for precise, targeted surgical delivery. Our focus is to transform the accuracy, safety and consistency of delivering therapeutics to patients. Located in Philadelphia, Orbit Biomedical was founded in 2018 with a Series A investment from
Syncona, a leading FTSE250 healthcare company focused on investing in and building global leaders in life science.
